| Previous Close | 35.45 |
| Open | 35.93 |
| Bid | 35.71 x 1200 |
| Ask | 36.20 x 200 |
| Day's Range | 35.81 - 36.21 |
| 52 Week Range | 29.83 - 36.21 |
| Volume | 412 |
| Avg. Volume | 17,361,603 |
| Market Cap | 214.05B |
| Beta | 1.06 |
| PE Ratio (TTM) | 26.33 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.61%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- MarketWatch•45 minutes ago
This squabble between two big drugmakers could have major implications for the U.S. health care system
Pfizer is suing Johnson & Johnson, alleging that it set up contracts to leave Pfizer’s Inflectra out in the cold.
- Reuters•4 hours ago
Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod
European regulators on Thursday granted market approval for Merck KGaA and Pfizer's immuno-oncology drug Bavencio to treat a rare and aggressive type of skin cancer called Merkel cell carcinoma. In May, ...
- Business Insider•5 hours ago
Pfizer is taking its fight with J&J over a blockbuster drug to court
Two of the world's largest drugmakers are heading to court over a blockbuster arthritis treatment...
